NUAK1 and neoplasm: Recent efforts have described small-molecule inhibitors targeting NUAK1/2 that have demonstrated in vitro efficacy against tumor cell proliferation and migratory potential, highlighting the possibility that NUAK1 may represent a therapeutic target (12).